Skip to main content
Caplight Logo









Veirulence Ltd

Veirulence Ltd

Private
LondonHealthcare & Life Scienceshttps://www.veirulence.com/

Last Round

Seed

Dec 25, 2024

Total Funding Raised

$2.53M

Company Overview

Veirulence Ltd is a biopharmaceutical company that develops non-antibiotic small molecule therapeutics targeting bacterial virulence factors to combat antimicrobial resistance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

antimicrobial resistanceAMRvirulence factor inhibitorsmall-molecule therapeuticsdrug discoverynon-antibiotic therapyanti-infectivepathogen researchc-di-GMP signalingswarming inhibitionbiotech startupsuperbug treatmentadjunctive therapybiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Veirulence Ltd Comparables

Compare Veirulence Ltd with similar companies based on industry and business-model similarity.

Veirulence Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Combioxin SA
77%
Inicure AB
74%
Helperby Therapeutics
72%

Veirulence Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 25, 2024
Pre SeedOct 14, 2024

Veirulence Ltd Investors

Notable investors and investment history

Veirulence Ltd investors
InvestorRounds
INCATEPre Seed
Innovate UKGrant
Oxford TechnologyPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 25, 2024

    $2M raised in Seed round.

  • Oct 14, 2024

    $148K round with Oxford Technology and INCATE

Veirulence Ltd Filings

Explore SEC and related filing metadata, where available.

Veirulence Ltd filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Veirulence Ltd's valuation, stock price, and market status.

Is Veirulence Ltd a public or private company?

Veirulence Ltd is a private company.

What is the current stock price of Veirulence Ltd?

Veirulence Ltd is a private company with no public stock price. Caplight tracks Veirulence Ltd's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Veirulence Ltd worth (valuation)?

Valuation information for Veirulence Ltd is not publicly available.

Can I buy Veirulence Ltd stock?

Veirulence Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Veirulence Ltd's last funding round?

Veirulence Ltd's most recent funding round was Seed on December 25, 2024.

Who are the main investors in Veirulence Ltd?

Key investors in Veirulence Ltd include INCATE, Innovate UK, Oxford Technology.

Will Veirulence Ltd IPO soon?

No public IPO plans have been announced for Veirulence Ltd.

How can I track Veirulence Ltd secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Veirulence Ltd's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Year Founded2022
Last FundingDec 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?